264 related articles for article (PubMed ID: 1838836)
21. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
[TBL] [Abstract][Full Text] [Related]
22. [Prostaglandin E1--the pharmacologic prosthesis].
de Boccard GA; Rochat CH
Ann Urol (Paris); 1993; 27(3):152-5. PubMed ID: 8352576
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
He L; Wen J; Jiang X; Chen H; Tang Y
Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
[TBL] [Abstract][Full Text] [Related]
24. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
[TBL] [Abstract][Full Text] [Related]
25. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
26. Use of prostaglandin E1 in the treatment of sexual impotence after heart transplantation: initial clinical experience.
Livi U; Faggian G; Sorbara C; Gambino A; Calabrò A; Artibani W; Bortolotti U; Pagano F
J Heart Lung Transplant; 1993; 12(3):484-6. PubMed ID: 8329422
[TBL] [Abstract][Full Text] [Related]
27. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
[TBL] [Abstract][Full Text] [Related]
28. A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
Wang CJ; Wu CC; Huang CH; Chiang CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):585-90. PubMed ID: 1296038
[TBL] [Abstract][Full Text] [Related]
29. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
Loran OB; Segal AS; Shcheplev PA
Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
[TBL] [Abstract][Full Text] [Related]
30. The use of prostaglandins for diagnosis and treatment of erectile impotence.
Merckx L; Vanwaeyenbergh J; De Bruyne R; Braeckman J; Keuppens F
Acta Urol Belg; 1991; 59(3):47-52. PubMed ID: 1759665
[TBL] [Abstract][Full Text] [Related]
31. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.
Porst H; van Ahlen H; Block T; Halbig W; Hautmann R; Löchner-Ernst D; Rudnick J; Staehler G; Weber HM; Weidner W
Vasa Suppl; 1989; 28():50-6. PubMed ID: 2609244
[TBL] [Abstract][Full Text] [Related]
32. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Valdevenito R; Melman A
Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
[TBL] [Abstract][Full Text] [Related]
33. [The use of PGE1 in the treatment of erectile deficiency].
Arena F; Peracchia G; Di Stefano C; Cortellini P
Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
[TBL] [Abstract][Full Text] [Related]
34. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
35. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
36. Intracavernous injection of prostaglandin E1 in impotent men.
Stackl W; Hasun R; Marberger M
J Urol; 1988 Jul; 140(1):66-8. PubMed ID: 3379700
[TBL] [Abstract][Full Text] [Related]
37. [Endocavernous drug infusions revisited].
Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
Dembe K; Jasik M; Piechna K
Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):19-20. PubMed ID: 8008670
[TBL] [Abstract][Full Text] [Related]
39. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
[TBL] [Abstract][Full Text] [Related]
40. [Intracavernous injections of vasoactive drugs. Contribution to the study of their value in erectile impotence].
Bondil P; Dorémieux J; Nguyen Qui JL
J Urol (Paris); 1987; 93(6):361-8. PubMed ID: 3323319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
